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Abstract
Unanticipated late effects in neutron and heavy ion therapy, not attributable to overdose, imply a qualitative difference between
low and high LET therapy. We identify that difference as ‘ion kill’, associated with the spectrum of  z/b in the radiation field,
whose measurement we label ‘ion-kill dosimetry’.
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1. Late Effects in Heavy Ion Therapy
Neutron therapy in the UK has been accompanied
by unanticipated late effects, associated with loss of
repair, leading to the closing of all three installations
[1]. Such effects have also been observed at Berke-
ley with silicon and neon [2]. In discussing expe-
rience with He and Ne, Castro [3] mentioned that
tumor doses were expressed in physical Gray and
Gray equivalent. He stated that this was of some
value with protons or helium but was not as valid
or useful for heavier ions such as neon. Further,
fractionation did not protect against late effects for
neon as is the case for low-LET radiation. In all
cases treatment planning was based on ‘biological
dose’, the product of RBE and physical dose. Since
extensive and accurate measurements of RBE pre-
ceded treatment, the failure cannot be attributed to
overdose. We must conclude that biological dose is
an inadequate concept for high LET therapy, though
adequate for protons and helions. A quantitative
dosimetry which recognizes the qualitative differen-
ce between photons and heavy ions is required. We
propose that such a dosimetry can be based on track
theory.
2. A Precis of Track Theory
To explain the shapes of survival curves observed
with many different cell lines and different particle
beams we invoked a theory of dual radiation action,
the two modes being called ion-kill and gamma-kill.
Ion-kill is the effect produced by single energetic
heavy ions traversing a cell nucleus, while gamma-
kill is the effect produced by delta rays from adja-
cent ions on cells at most sub-lethally inactivated by
single ion traversals. In both cases the effects are
produced by delta rays, but the high concentration
of low energy delta rays close to an ion’s path is
a much more severe effect than that produced by the
dispersed delta rays from different ions in the gam-
ma-kill mode.
Gamma-kill physically resembles the inactivation
by the Compton- and photo-electrons from photon
irradiation. Ion–kill is responsible for all high-LET
effects: elevated RBE, reduced OER, loss of repair,
insensitivity to cell cycle differences.
In the theory the probability for ion-kill is used
as an approximation for the fraction of the dose
consumed in the ion-kill mode, with the residue
called the gamma-kill dose. Ion-kill effects are cal-
culated from the ion-kill cross section and the par-
ticle fluence, while gamma-kill effects are calcula-
ted from the same multi-target formula used for
calculating the survival curve for gamma-rays. Thus
the gamma-kill dose is fully equivalent to an equal
photon dose, as confirmed by our calculations of the
effects of radiation fields in which neutrons were
admixed with photons [4].
The theory requires the evaluation of four radiosen-
sitivity parameters from a collection of survival cur-
ves after exposure to particle beams of different com-
position and LET. Once evaluated these parameters
are used to calculate the response of arbitrary radia-
tion fields whose particle-energy spectrum is known
from calculation, for this measurement is presently
impossible. But the theory has shown that an arbi-
trary radiation field can be reduced to the total ion-
kill probability, and the total gamma-kill dose. The
ion-kill probability can be calculated from the distri-
bution in the spectrum of z/b in the radiation field and
the radiosensitivity parameters. From the theory a
measurement of total dose, and a measurement of the
ion-kill probability can yield calculations of cell sur-
vival, RBE and OER for those cells where in vitro
measurements have yielded radiosensitivity parame-
ters [5]. We anticipate that clinical experience will
identify the choice of radiosensitivity parameters
appropriate to different tissues and the levels of ion-
kill and dose correlated with unacceptable complica-
tions in high LET therapy.
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3. Calculations of Ion-Kill, RBE, and cell sur-
vival in a 2 cm spread Bragg Peak
To investigate the relation of ion-kill to these
problems we have calculated profiles of cell sur-
vival, physical dose, RBE, and probability for
survival in the ion-kill mode for beams of H, He,
C, and Ne, in a 2 cm spread Bragg peak, for which
there is 30% iso-survival [6]. This paper should be
consulted for further background, formulas and
illustrations for which there is no space here. The
regular decrease in ion-kill from neon through
carbon and helium to protons is consistent with
clinical observation of late effects, and has led us
to identify ion-kill as the source of this problem.
Although we have not yet calculated the distribution
of ion-kill probability as a function of depth in
neutron irradiated tissue, some of our earlier work
[7] yielded a calculation of the ion- kill probability
for neutrons of known initial energy for which the
fragment particle-energy distribution had been cal-
culated from experimental cross sections (Caswell
and Coyne and Dennis, pvt. communication). There
the ion kill probability increased regularly from
about 0.24 for 14 MeV neutrons to 0.65 for 0.5
MeV neutrons, for hamster cells, with small varia-
tion for other cell lines. The neutron energy spectrum
for the MRC installation at Hammersmith hospital
yielded a value of 0.2, while that from pion stars
was 0.15.
4. Ion Kill Dosimetry
Now, as to ion kill dosimetry. Clearly, we require
discriminating detectors, which respond preferen-
tially to single energetic heavy ions compared to
single electrons or protons, as is the case for
biological cells. Studies from track theory have
identified a number of such discriminating detectors
in physics and chemistry. Our preferred initial
selection is the class of solid state track etch
detectors where a heavy ion transit through the
detector creates a latent damage trail which is
exposed by chemical etching. In their application
to the measurement of the particle spectrum of
cosmic rays it has been useful to correlate ‘etching
rate’, the size of etch pits after specified etching
times, to z/b [8]. Different detectors span a range
of this quantity from 10 to 250 for relativistic
cosmic rays. They can be expected to be useful for
the evaluation of the biological effect of single
heavy ions in space. We will investigate their utility
for the spectrum of energetic heavy ions in cancer
therapy. Knowledge of the spectrum of z/b in tissue
may be converted to the spectrum of ion kill
probability by use of track theory. We anticipate
that this new information will aid radiation onco-
logists in their treatment planning, to avoid late
effects while yet taking advantage of the beneficial
effects of high LET radiation
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